Gianpiero Gravante: Comparative Evaluation of Surgical Strategies for Grade III Hemorrhoidal Disease
Gianpiero Gravante, Member of the Board of Advisors HEMM AI, Guidelines and Multidisciplinary Management Committee Member at SICCR, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Techniques in Coloproctology, adding:
“New PUB!
Pleased to share our latest publication in Techniques in Coloproctology.
In this large retrospective cohort study (n = 686), we compared different surgical strategies for grade III hemorrhoidal disease, including Milligan–Morgan hemorrhoidectomy, mucopexy, and hybrid approaches.
- Our findings highlight a clear trade-off: Mucopexy (and hybrid techniques) showed lower postoperative pain and better early patient-reported outcomes
- Milligan–Morgan provided superior long-term results, with significantly lower recurrence rates
These data reinforce the need to move beyond a ‘one-size-fits-all’ approach.
A tailored, patient- and pile-specific strategy may better balance short-term morbidity with long-term efficacy in grade III hemorrhoids.
Grateful to all co-authors and collaborators involved in this work.”
Title: Milligan–Morgan hemorrhoidectomy, mucopexy, and hybrid combination for grade III hemorrhoids: a large retrospective cohort study
Authors: Gaetano Gallo, Veronica De Simone, Gianpiero Gravante, Salvatore Sorrenti,Simone Tierno, Federico Tomassini, Antonio Crucitti, Pierpaolo Sileri, Marco La Torre
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 26, 2026, 05:03Ursula Porage Dona: From Inspiring Knowledge to Hearing Firsthand Stories
-
Apr 26, 2026, 04:34ASH – ISTH Pediatric VTE Prophylaxis Guidelines in The ASCO Post
-
Apr 25, 2026, 17:10Abdul Mannan: 10-Minute FVIII Inhibitor Screening Test
-
Apr 25, 2026, 16:55Connie Montgomery: Highlights from the Hemophilia Federation of America Symposium 2026
-
Apr 25, 2026, 16:35Fernanda Aspilche: Bringing the Alpha-1 Community to the European Parliament
-
Apr 25, 2026, 15:49Brian O Mahony: Expanding the Non-Replacement Therapy Toolbox
-
Apr 25, 2026, 15:44Toong Youttananukorn: Six Abstracts Demonstrate the Impact of WBDR at WFH Congress 2026
-
Apr 25, 2026, 15:29Craig Beavers: Pharmacist’s Role in Management of Patients With Valvular Heart Disease
-
Apr 25, 2026, 15:08Lakmali Silva: Just Back from a Truly Energising Days in the UNC 12th Symposium on Hemostasis